Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease, a rare and progressive neurological disorder with no approved therapies....
UniXell secures US FDA clearance for Parkinson's disease cell therapy
UniXell Biotechnology has received Investigational New Drug (IND) clearance from the US Food and Drug Administration (FDA) for UX-DA003, its allogeneic induced pluripotent stem cell (iPSC)-derived therapy for Parkinson's disease. The approval follows the candidate's earlier IND clearance from China...
Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen
Praxis Precision Medicines has received US Food and Drug Administration (FDA) Breakthrough Therapy Designation for elsunersen (PRAX-222) to treat seizures associated with SCN2A Developmental and Epileptic Encephalopathy (SCN2A-DEE) caused by gain-of-function variants in the SCN2A gene....
Merck’s Calderasib Receives FDA Breakthrough Therapy Designation for Lung Cancer
Merck has secured a significant regulatory milestone for its investigational cancer therapy, calderasib (MK-1084), after the U.S. Food and Drug Administration (FDA) granted the treatment Breakthrough Therapy designation....
MannKind Secures FDA Approval for Afrezza in Pediatric Diabetes
MannKind Corporation has received US Food and Drug Administration (FDA) approval for Afrezza® (insulin human) Inhalation Powder for children and adolescents aged six years and older with type 1 or type 2 diabetes....
VERTANICAL Secures FDA Breakthrough Therapy Status for VER-01 for Chronic Back Pain
VERTANICAL has achieved an important regulatory milestone after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to VER-01, an investigational non-opioid therapy being developed for chronic low back pain....
FDA Approves Regeneron’s First-in-Class Gene Therapy for OTOF Hearing Loss
Regeneron Pharmaceuticals has received FDA accelerated approval (lunsotogene parvec-cwha), a gene therapy for patients with severe-to-profound sensorineural hearing loss caused by OTOF gene mutations....
Galmed Announces Breakthrough Brain-Penetrating Formulation of Aramchol for CNS Disorders
Galmed Pharmaceuticals Ltd. has announced the development of a brain-penetrating formulation of its SCD1 inhibitor, Aramchol, designed for potential use in central nervous system (CNS) diseases including Parkinson’s disease....
Novo Nordisk Receives FDA Approval for Awiqli®, a Once-Weekly Basal Insulin for Type 2 Diabetes
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first once-weekly, long-acting basal insulin for adults with type 2 diabetes....
Unexpected Laboratory Result Opens New Path in Drug Development Chemistry
Scientists at the University of Cambridge have discovered a new light-driven chemical reaction that could make drug development faster and more sustainable....
